Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/173027
Title: Targeting Cx43 to reduce the severity of pressure ulcer progression
Authors: Kwek, Milton Sheng Yi
Thangaveloo, Moogaambikai
Madden, Leigh
Phillips, Anthony R. J.
Becker, David Lawrence
Keywords: Science::Medicine
Issue Date: 2023
Source: Kwek, M. S. Y., Thangaveloo, M., Madden, L., Phillips, A. R. J. & Becker, D. L. (2023). Targeting Cx43 to reduce the severity of pressure ulcer progression. Cells, 12(24), 2856-. https://dx.doi.org/10.3390/cells12242856
Project: H17/01/a0/0C9 
H1701a0004 
Journal: Cells 
Abstract: In the skin, repeated incidents of ischemia followed by reperfusion can result in the breakdown of the skin and the formation of a pressure ulcer. Here we gently applied paired magnets to the backs of mice to cause ischemia for 1.5 h and then removed them to allow reperfusion. The sterile inflammatory response generated within 4 h causes a stage 1 pressure ulcer with an elevation of the gap junction protein Cx43 in the epidermis. If this process is repeated the insult will result in a more severe stage 2 pressure ulcer with a breakdown of the epidermis 2-3 days later. After a single pinch, the elevation of Cx43 in the epidermis is associated with the inflammatory response with an increased number of neutrophils, HMGB1 (marker of necrosis) and RIP3 (responsible for necroptosis). Delivering Cx43 specific antisense oligonucleotides sub-dermally after a single insult, was able to significantly reduce the elevation of epidermal Cx43 protein expression and reduce the number of neutrophils and prevent the elevation of HMGB1 and RIP3. In a double pinch model, the Cx43 antisense treatment was able to reduce the level of inflammation, necroptosis, and the extent of tissue damage and progression to an open wound. This approach may be useful in reducing the progression of stage 1 pressure ulcers to stage 2.
URI: https://hdl.handle.net/10356/173027
ISSN: 2073-4409
DOI: 10.3390/cells12242856
Schools: Lee Kong Chian School of Medicine (LKCMedicine) 
Organisations: Skin Research Institute, Singapore 
Rights: © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Fulltext Permission: open
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles

Files in This Item:
File Description SizeFormat 
cells-12-02856-v2.pdf7.22 MBAdobe PDFThumbnail
View/Open

SCOPUSTM   
Citations 50

3
Updated on May 4, 2025

Page view(s)

387
Updated on May 6, 2025

Download(s) 20

296
Updated on May 6, 2025

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.